What was Wuhan General Group [China]’s price range in the past 12 months?
Wuhan General Group [China] lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Wuhan General Group [China]’s market cap?
Wuhan General Group [China]’s market cap is $16.55K.
When is Wuhan General Group [China]’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wuhan General Group [China]’s earnings last quarter?
Wuhan General Group [China] released its earnings results on Aug 16, 2021. The company reported -$0.005 earnings per share for the quarter.
Is Wuhan General Group [China] overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Wuhan General Group [China] pay dividends?
Wuhan General Group [China] does not currently pay dividends.
What is Wuhan General Group [China]’s EPS estimate?
Wuhan General Group [China]’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wuhan General Group [China] have?
Wuhan General Group [China] has 55,149,662 shares outstanding.
What happened to Wuhan General Group [China]’s price movement after its last earnings report?
Wuhan General Group [China] reported an EPS of -$0.005 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Wuhan General Group [China]?
Currently, no hedge funds are holding shares in WUHN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wuhan General Group [China]
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jeff Robinson
Employees
700
Website
wuhn.org
Address
401 Ryland St. Ste 200-A, Reno, NV, 89502, US
Wuhan General Group [China] (WUHN) Earnings & Revenues